Table I.
Association between miR-613 expression and clinicopathological characteristics of patients with non-small cell lung cancer.
| Characteristics | miR-613 low expression (n=16) | miR-613 high expression (n=16) | P-valuea |
|---|---|---|---|
| Age, years | >0.05 | ||
| ≤65 | 7 | 8 | |
| >65 | 9 | 8 | |
| Sex | >0.05 | ||
| Male | 9 | 10 | |
| Female | 7 | 6 | |
| Histological subtype | >0.05 | ||
| Squamous cell carcinoma | 10 | 8 | |
| Adenocarcinoma | 6 | 8 | |
| TNM stage | 0.029 | ||
| I–II | 3 | 10 | |
| IIIa | 13 | 6 | |
| Tumor size, cm | 0.032 | ||
| ≤5 | 4 | 11 | |
| >5 | 12 | 5 | |
| Lymph node metastasis | 0.023 | ||
| Negative | 2 | 9 | |
| Positive | 14 | 7 | |
| Smoking history | >0.05 | ||
| Smokers | 13 | 12 | |
| Never smokers | 3 | 4 |
a
χ2 test. miR-613, microRNA-613.